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Abstract
Background
Cardiovascular diseases are the leading cause of death worldwide and in Switzerland.
When applied, treatment guidelines for patients with acute ST-segment elevation myocar-
dial infarction (STEMI) improve the clinical outcome and should eliminate treatment differ-
ences by sex and age for patients whose clinical situations are identical. In Switzerland, the
rate at which STEMI patients receive revascularization may vary by patient and hospital
characteristics.
Aims
To examine all hospitalizations in Switzerland from 2010–2011 to determine if patient or
hospital characteristics affected the rate of revascularization (receiving either a percutane-
ous coronary intervention or a coronary artery bypass grafting) in acute STEMI patients.
Data and Methods
We used national data sets on hospital stays, and on hospital infrastructure and operating
characteristics, for the years 2010 and 2011, to identify all emergency patients admitted
with the main diagnosis of acute STEMI. We then calculated the proportion of patients who
were treated with revascularization. We used multivariable multilevel Poisson regression to
determine if receipt of revascularization varied by patient and hospital characteristics.
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Results
Of the 9,696 cases we identified, 71.6% received revascularization. Patients were less likely
to receive revascularization if they were female, and 80 years or older. In the multivariable
multilevel Poisson regression analysis, there was a trend for small-volume hospitals per-
forming fewer revascularizations but this was not statistically significant while being female
(Relative Proportion = 0.91, 95% CI: 0.86 to 0.97) and being older than 80 years was still
associated with less frequent revascularization.
Conclusion
Female and older patients were less likely to receive revascularization. Further research
needs to clarify whether this reflects differential application of treatment guidelines or limita-
tions in this kind of routine data.
Introduction
Mortality for cardiovascular diseases (CVDs) has continually decreased in developed countries,
but CVDs are still the leading cause of death in Switzerland for both sexes [1]. More rapid and
improved treatment of acute myocardial infarction (AMI) has substantially reduced CVDmor-
tality [2]. International guidelines recommend, for optimal treatment, that AMI patients
receive evidence-based therapies [3–5]. Treatment guidelines differ by type of AMI: ST-eleva-
tion myocardial infarction (STEMI) is differentiated from non-ST-elevation myocardial infarc-
tion (NSTEMI). If treatment guidelines are consistently followed, they should reduce or
eliminate sex- or age-based treatment differences for patients whose clinical situations are
identical.
In Switzerland, however, there is evidence that AMI patients are treated inconsistently, and
that guidelines are more likely to be followed for men than for women. Radovanovic et al ana-
lyzed patients of the Swiss AMI registry (AMIS) between 1997–2011 and saw that percutaneous
coronary interventions (PCI) had increased in STEMI patients overall. But, since 2006, they
found that over 80% of male patients received PCI, while only 70% of women were treated with
PCI [6]. Women were less likely to receive primary reperfusion (thrombolysis and PCI) and
medications according to evidence-based guidelines [6,7]. Other studies documented that AMI
treatment in Switzerland varied by region, hospital characteristics (presence or absence of 24
hour/7day cardiac catheterization facility), age, and number of comorbidities [7–9].
We used nation-wide hospital data of patients admitted to all Swiss hospitals in 2010 and
2011, with the goal of including all patients with acute STEMI as their main diagnosis because
well-established treatment guidelines exist for these patients [3]. Our goal was to investigate
the effect of patient and hospital characteristics on receipt of revascularization in acute STEMI
patients accounting for hospital transfers and use of treatment information over the whole
course of treatment.
Data and Methods
Ethics
Ethical approval was not required for this analysis of data, which are available to research insti-
tutions according to the ordinance on federal statistical monitoring activities and surveys.
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collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: The authors have declared
that no competing interests exist.
Data sets
We used two national data sets from the Swiss Federal Statistical Office (SFSO) that provided
information about inpatient care and hospital infrastructure in 2010 and 2011. The first data
set,Medizinische Statistik der Krankenhäuser, focuses on hospital stays (HS) and includes man-
datory information on all patients hospitalized for at least a day, recording age, sex, place of
residence, date of admission and discharge (month) of the patient, as well as main and con-
comitant diagnoses, and treatment provided. The second data set, Krankenhausstatistik,
focuses on hospital characteristics (HC) and contains information on hospital infrastructure
for all hospitals in Switzerland, including type of hospital, number of beds, number of physi-
cians and nurses, number of angiography devices, CT or MRI machines, presence of an emer-
gency room. The information in these data sets can be cross-referenced by hospital-ID. To
ensure data is protected, the patient residence and the geographical location of the hospital are
aggregated into zip code areas consolidated into 705 medical statistics (Medstat) regions.
Ethical approval was not required for this analysis of data, which are available to research
institutions according to the ordinance on federal statistical monitoring activities and surveys.
We used the community classification data set (Raumgliederung) from the SFSO (reference
date December 31st, 2010) to determine the level of urbanization of Medstat regions. The vari-
able urban/rural region in the community classification data set included four categories: (1)
main city of an agglomeration; (2) other agglomeration community; (3) isolated city; and, (4)
rural community. One Medstat region usually contains more than one community. If at least
one community in the Medstat region was classified as 1, 2 or 3, we coded the whole Medstat
region as urban. Otherwise we coded it as rural.
Construction of course of treatment
The years 2010–2011 included a total of 2,708,942 hospital stays (2010: 1.345.245; 2011:
1,363,697; Fig 1). We excluded 44,338 records for which date of entry, date of exit, hospital-ID
or patient-ID were missing. Of that, the majority (99.7%) had no date of exit because these
patients were hospitalized over New Year. So they had an incomplete record the year they
entered the hospital and a complete record the year they were discharged. So we excluded them
to eliminate duplicates and just use complete records. To protect patient anonymity, the treat-
ing hospital uses a Hash code (derived from the patient’s name, gender and date of birth) to
create a patient ID, which can be used to track patients with multiple hospital stays, either in
the same, or in another hospital.
Patients with several hospital stays recorded close together may have been referred between
hospitals to treat the same condition. For example, STEMI patients would be recorded twice in
the HS data if they were treated in one hospital for a day, and then transferred to spend several
days in another hospital for further treatment. To avoid double counting of patients, we recon-
structed each of these short courses of treatment, searching for sequential hospitalizations in
the HS record by patient-ID, sequence number, days to next hospitalization (< = 1), and
month of entry. A case may thus contain several hospital stays. For the years 2010 and 2011,
we constructed 2,418,502 full cases.
Selection of STEMI patients
The International Classification of Diseases, Injuries and Causes of Death (ICD) 10 codes were
used to code main and secondary diagnoses in the HS data set. The ICD 10 code that starts
with I21 is for acute transmural myocardial infarctions. To select AMI patients with STEMI
specifically, we excluded cases with acute subendocardial myocardial infarction (I21.4) and
unspecified acute myocardial infarction (I21.9). Cases with acute transmural myocardial
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infarction of anterior wall (I21.0), acute transmural myocardial infarction of inferior wall
(I21.1), acute transmural myocardial infarction of other sites (I21.2) or acute transmural myo-
cardial infarction of unspecified site (I21.3) were included. These four main diagnoses (I21.0,
I21.1, I21.2, and I21.3) had to appear at the first or second hospitalization record. If mentioned
on the second record we restricted the selection to cases matching predefined main diagnoses
at the first record (see S1 Table). We chose these predefined diagnoses as they have similar
symptoms like AMI and we wanted to identify just patients being hospitalized as an emergency
with AMI. We only included cases if the first record was an emergency admission. This way we
excluded patients with planned hospital stays, who were unlikely to have an acute STEMI.
After applying these restrictions, we included 9,696 full treatment cases in our analysis.
Information on treatment received
To describe the treatments that STEMI patients received, we considered all records of treat-
ment for each case. We coded information on treatment procedures in the HS data according
to the Swiss operation classification system (CHOP), which was derived and modified from the
American International Classification of Diseases, Ninth Revision, Clinical Modification: ICD-
9-CM, volume 3, 1994. We also coded it according to classification in All Patient Diagnosis
Related Groups (APDRG). We classified the 9,696 AMI cases into four groups, based on avail-
able treatment information: (1) codes that indicated a PCI; (2) codes that indicated a coronary
artery bypass grafting (CABG); (3) codes that indicated treatments other than PCI or CABG;
and, (4) patients with no available treatment codes (see S2 and S3 Tables for the exact CHOP
Fig 1. Flow chart of the selection process.
doi:10.1371/journal.pone.0153326.g001
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and APDRG codes we used). We then created a variable that described if patients were treated
with revascularization (PCI, CABG, or both) or not.
Patient characteristics
We assessed the following socio-demographic variables: sex, age (grouped 18–44, 45–49, 50–
54, 55–59, 60–64, 65–69, 70–74, 75–79, 80–84, 85+ years), and nationality (Swiss, foreign). As
a proxy for the patient’s socio-economic position, we used the patients insurance status (public,
semi-private, or private), which indicates the type of insurance used for billing. Public insur-
ance is mandatory, semi-private and private insurance are optional and paid for by patients in
addition to paying public insurance. Semi private insurance is associated with a hospital stay in
a two-bed room, private insurance with a stay in a single-bed room. We also used information
on who referred the patient to the hospital (the patient or relatives, rescue service or a physi-
cian). To characterize the comorbidities of the patient, we used the maximum number of sec-
ondary diagnoses recorded either in the first or, if the patient was referred, the second record
in the HS data (grouped into no, 1 to 2, 3 to 4, 5 to 6, and 7 or more secondary diagnoses).
Hospital characteristics
We used the following hospital level information: presence of an angiography device; full-time
equivalent (FTE) of the physicians by 1,000 cases (grouped into tertiles); type of hospital region
(urban or rural); language region of the hospital (German, French or Italian); and the number
of hospital stays per year. As has been done previously [10], we divided hospitals into three
groups: small-volume (<15,001 cases/year), medium-volume (15,001–30,000 cases/year) or
high-volume (> 30,000 cases/year) volume.
Except for treatment information and comorbidities, we derived both patient and hospital
characteristics from the first hospital stay of the short course of treatment. Coding guidelines
for HS data imply that the referring hospital coded the treatment when it referred a patient to
another hospital for ambulatory treatment, e.g., an ambulatory PCI. This explains why we
focused on the first hospital, which also took the lead in providing treatment and made the
decision to refer a patient to another hospital.
Statistical analysis
We calculated the number and percentage of patients who received revascularization and com-
puted crude relative proportions with 95% confidence intervals (95% CI) when comparing
groups of patients. We used Pearson Chi-square-test with a two-sided significance level
p<0.05 to test for differences by patient or hospital characteristics. We then estimated relative
proportions using multivariable multilevel Poisson regression to adjust for confounders and to
identify characteristics independently associated with receiving revascularization [11]. We
included patient characteristics (sex, age, nationality, bed category, maximum number of sec-
ondary diagnoses at first or second hospital, entry decision) and hospital characteristics (angi-
ography device, fulltime equivalent of physicians per 1,000 cases, type of hospital region,
language region, and hospital groups). We used multilevel Poisson regression as implemented
in Stata, with the xtpoisson command, to account for the multilevel structure of the data (clus-
tering of patients within the first contact hospital), and used Wald tests to examine the signifi-
cance of association. In the analyses of variables with ordered levels we used the lowest level as
the reference group and for dichotomous variables the level without the corresponding charac-
teristic. We performed a sensitivity analysis by analyzing treatment with PCI alone, excluding
CABG and found no major differences between the model with PCI alone and the model with
Revascularization Treatment of STEMI Patients in Swiss Hospitals
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PCI/CABG, hence we used PCI/CABG in all further analyses. All analyses were performed
using Stata version 13 (StataCorp, College Station, TX, USA).
Results
In Switzerland, in 2010 and 2011, 300 hospitals provided inpatient care, including specialized
services for acute care, psychiatry, rehabilitation/geriatrics, or delivery/obstetrics. More than
half these hospitals had an acute care division (2010: 179, 2011: 180). Of these 300 hospitals, 98
were the site of first contact in 2010, and 96 in 2011, for the 9,696 STEMI cases we included. In
both years, 77 of the hospitals were located in an urban area. Of the first contact hospitals, 54
in 2010, and 56 in 2011, had at least one angiography device. Over both years, 35.4% of the
included STEMI patients were initially treated in a small-volume hospital, 31.9% in a medium-
volume hospital, and 32.6% in a high-volume hospital.
Study population
The 9,696 STEMI cases (total: 9,598 different persons) were, on average, 65.8 years old (range:
18–102 years); 70.8% were male, and the mean length of stay was 11.7 days. In the group
treated with revascularization (6,946 of the 9,696, or 71.6% of all), mean age was 63.3 years,
75.6% were men, and average length of stay was 11.4 days. The 2,750 patients who did not
receive revascularization were, on average, 72 years old; 58.7% were male, and mean length of
stay was 12.5 days.
The proportion of cases who received revascularization was highest in the 50–54 age group
(83.5%), and lowest in the 85+ years age group (29.6%). The proportion was highest in the pri-
vate (76.8%), and lowest in the public insurance category (70.9%). It was highest in the high-
volume hospital group (81.3%), and lowest in the small-volume hospital group (55.3%). In the
Italian hospital language region, 80.6% of all hospitalized STEMI cases received revasculariza-
tion, while in the French language region, 70.9% received the treatment (see Table 1).
Factors associated with receiving a revascularization
The results of the univariable Poisson regression analyses showed revascularization was less
common in female patients, those older than 69 and those who were Swiss (see Table 1).
Patients were more likely to receive revascularization if they were referred to the hospital by
their physician, had any secondary diagnoses, were in the private insurance category, were first
treated in a medium- or high-volume hospital, or were hospitalized in the Italian language
region. The relative proportion of revascularization treatments increased with the number of
FTE of physicians per 1,000 cases. Patients treated in an urban hospital, and in hospitals with
an angiography device were more likely to receive revascularization.
In the multivariable multilevel Poisson regression analysis most of these associations disap-
peared, while following associations persisted: A negative association of revascularization with
being female (RP = 0.91, 95% CI: 0.86 to 0.97) and with being 80 years and older (age group
80–84 years: RP = 0.80, 95% CI: 0.70 to 0.91; age group 85+ years: RP = 0.42, 95% CI: 0.36 to
0.49). Having more comorbidities did not reduce the likelihood for revascularization (see Fig 2
and S4 Table).
Furthermore, we present (Figs 3 and 4; S5 and S6 Tables) separate multilevel Poisson regres-
sion analyses for men and women, stratified by age (younger age group: 18–64 years, older age
group: 65+ years).
Having comorbidities wasn’t a limiting factor to receive revascularization for young or old
men and old women. In the adjusted analyses, revascularization was lower for men and women
over 80. Women in the older age group had more often revascularization (RP = 1.18, 95% CI:
Revascularization Treatment of STEMI Patients in Swiss Hospitals
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Table 1. Socio-demographic, socioeconomic and healthcare-related factors of the study population and crude rates of receiving a revasculariza-
tion, Switzerland 2010–2011.
N (%) PCI/CABG (%) Unadjusted model crude
relative proportions (95% CI)
Total 9,696 (100.00%) 6,946 (71.64%)
Sex p<0.0000 p<0.0000
Male 6,869 (70.84%) 5,254 (76.49%) 1.0
Female 2,827 (29.16%) 1,692 (59.85%) 0.78 (0.76,0.81)
Age groups p<0.0000 p<0.0000
18 to 44 years 567 (5.85%) 454 (80.07%) 1.0
45 to 49 years 727 (7.50%) 594 (81.71%) 1.02 (0.97,1.08)
50 to 54 years 988 (10.19%) 825 (83.50%) 1.04 (0.99,1.10)
55 to 59 years 1,113 (11.48%) 888 (79.78%) 1.00 (0.95,1.05)
60 to 64 years 1,189 (12.26%) 946 (79.56%) 0.99 (0.94,1.04)
65 to 69 years 1,174 (12.11%) 952 (81.09%) 1.01 (0.96,1.06)
70 to 74 years 1,003 (10.34%) 756 (75.37%) 0.94 (0.89,0.99)
75 to 79 years 1,063 (10.96%) 727 (68.39%) 0.85 (0.81,0.91)
80 to 84 years 916 (9.45%) 521 (56.88%) 0.71 (0.66,0.76)
85+ years 956 (9.86%) 283 (29.60%) 0.37 (0.33,0.41)
Citizenship p<0.0000 p<0.0000
Foreign 1,731 (17.85%) 1,331 (76.89%) 1.0
Swiss 7,965 (82.15%) 5,615 (70.50%) 0.92 (0.89,0.94)
Entry decision p<0.0386 p<0.0382
Herself/Himself, relatives 2,415 (24.91%) 1,693 (70.10%) 1.0
Rescue services 3,730 (38.47%) 2,659 (71.29%) 1.02 (0.98,1.05)
Physician 3,551 (36.62%) 2,594 (73.05%) 1.04 (1.01,1.08)
Comorbidities p<0.0000 p<0.0000
No 276 (2.85%) 91 (32.97%) 1.0
1–2 2,298 (23.70%) 1,757 (76.46%) 2.32 (1.96,2.75)
3–4 3,072 (31.68%) 2,384 (77.60%) 2.35 (1.99,2.79)
5–6 1,908 (19.68%) 1,415 (74.16%) 2.25 (1.90,2.67)
7+ 2,142 (22.09%) 1,299 (60.64%) 1.84 (1.55,2.18)
Insurance status p<0.0030 p<0.0013
Public 7,700 (79.41%) 5,462 (70.94%) 1.0
Half Private 1,401 (14.45%) 1,027 (73.30%) 1.03 (1.00,1.07)
Private 595 (6.14%) 457 (76.81%) 1.08 (1.03,1.13)
Hospital groups p<0.0000 p<0.0000
Small (<15001 cases) 3,435 (35.43%) 1,900 (55.31%) 1.0
Medium (15001–30000 cases) 3,097 (31.94%) 2,475 (79.92%) 1.44 (1.40,1.50)
High (>30000 cases) 3,164 (32.63%) 2,571 (81.26%) 1.47 (1.42,1.52)
Language region p<0.0000 p<0.0000
German 7,140 (73.64%) 5,085 (71.22%) 1.0
French 2,052 (21.16%) 1,455 (70.91%) 1.00 (0.96,1.03)
Italian 504 (5.20%) 406 (80.56%) 1.13 (1.08,1.18)
FTE physicians/1000 cases p<0.0000 p<0.0000
1. tertile (<11.86) 3,236 (33.37%) 1,932 (59.70%) 1.0
2. tertile (11.86-<17.46) 3,300 (34.03%) 2,454 (74.36%) 1.25 (1.20,1.29)
3. tertile (17.46+) 3,151 (32.50%) 2,556 (81.12%) 1.36 (1.31,1.40)
n/a 9 (0.09%) 4 (44.44%)
(Continued)
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Table 1. (Continued)
N (%) PCI/CABG (%) Unadjusted model crude
relative proportions (95% CI)
Hospital region p<0.0000 p<0.0000
Rural 504 (5.20%) 230 (45.63%) 1.0
Urban 9,192 (94.80%) 6,716 (73.06%) 1.60 (1.45,1.76)
Angiography device p<0.0000 p<0.0000
No 1,290 (13.30%) 666 (51.63%) 1.0
Yes 8,406 (86.70%) 6,280 (74.71%) 1.45 (1.37,1.53)
doi:10.1371/journal.pone.0153326.t001
Fig 2. Results of multilevel Poisson regression for revascularization.
doi:10.1371/journal.pone.0153326.g002
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1.01 to 1.38) if their insurance status was semi-private. Young and old men as well as young
women were more often treated with revascularization when admitted first to a medium size
hospital (young men: RP = 1.29, 95% CI: 1.03 to 1.60; old men: RP = 1.32, 95% CI: 1.10 to 1.58;
young women: RP = 1.38, 95% CI: 1.05 to 1.81).
In a sensitivity analysis we excluded cases which died the same day of admission, were 85
+ years old or were admitted to hospitals with less than 3000 cases/year. This left 8,188 cases
for the analysis. The stratified models showed that being hospitalized first in a small hospital
led to less revascularization than an admission to a medium or high-volume hospital. The full
model showed no significant association.
Fig 3. Results of multilevel Poisson regression for revascularization for male and female patients
younger than 65 years.
doi:10.1371/journal.pone.0153326.g003
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Discussion
Main findings
In patients with acute ST-segment elevation myocardial infarction admitted as emergencies to
Swiss hospitals in 2010 and 2011, close to three-quarters (71.6%) received revascularization.
Women were less likely than men to be treated with PCI or CABG. Independent of other
patient and hospital characteristics, patients 80 years and older underwent revascularization
less frequently. In younger women, we observed no incremental association with number of
comorbidities. Compared to patients with no comorbidities, having comorbidities was not a
barrier to receive revascularization for old male and female patients as well as for young men.
Patients admitted to a medium-sized (15001–30000 hospitalizations per year) hospital were
more likely to receive a PCI or CABG. In a sensitivity analysis excluding patients died the day
Fig 4. Results of multilevel Poisson regression for revascularization for male and female patients 65
years and older.
doi:10.1371/journal.pone.0153326.g004
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of admission, patients being 85 years and older or admitted to hospitals with less than 3000
cases/year we found a positive trend for revascularization when admitted to a medium or high-
volume hospital compared to cases first hospitalized in a small hospital.
Limitations and strengths
Our study had some limitations. We used secondary data that was not collected for our study
purpose, so we did not know why patients received no revascularization, or what kind of medi-
cation they received. For patients treated in more than one hospital, coding guidelines limit our
ability to clearly determine which hospital provided which treatment [12]. We addressed this
in two ways. First, for our analysis, we used the characteristics of the first hospital a patient
went to. Second, we used treatment information across all hospitals in which a patient stayed
during the course of treatment.
We chose the ICD-10 codes I21.0, I21.1, I21.2 and I21.3 to identify STEMI cases after con-
sulting cardiologists and a coding expert from the Bern University hospital. ICD-10 codes do
not distinguish between STEMI or NSTEMI cases [13,14]. Although they found difficulties in
identifying the correct proportion of STEMI and NSTEMI on the bases of ICD-10 Alexan-
drescu et al. suggest to use I22.0, I22.1 and I22.8 additional to our chosen codes (I21.0-I21.3) to
identify STEMI cases. When we included these ICD-10 codes, additional 44 cases were identi-
fied with almost identical results when included in the regression analyses.
We lacked specific information about the capability of a hospital to offer revascularization,
and used the presence of an angiography device as a proxy without information about service
hours of catheter labs (e.g. 24/7). Since treatments are coded, and diagnoses are made at the
hospital where the patient is treated, coding practices may differ between hospitals e.g. due to
variation in adherence to coding guidelines; this could introduce differential misclassification.
The official coding guidelines are changed almost yearly. To limit the impact of changes, we
restricted our analysis to 2010 and 2011. Although we used multilevel multivariable regression
analyses, we cannot exclude residual confounding, bias due to variation of data collection pro-
cedures across hospitals, especially in information on prognostic factors of patients.
We examined the referral pattern per hospital group and the length of stay to consider dif-
ference in comorbidity coding. Of the 3,771 cases being transferred, 773 had no comorbidities
coded in the first hospital. Considering the length of stay of these cases 88.4% (683) left the
first hospital to another hospital the same day they were admitted. Therefore we believe that
due to the short length of stay the registration of the comorbidities of the patient was poor in
the first hospital. To overcome these differences in comorbidity coding we decided to use the
maximum number of comorbidities at the first or second hospital. In a first analysis we used
the number of comorbidities coded just by the first hospital. We found that having more than
six comorbidities leads to less revascularization. We are convinced that the new variable of the
maximum number of comorbidities is a better proxy for the real number of comorbidities of
the patients. Nevertheless, this improvement is just referring to cases which were transferred.
Our study has several strengths. We analyzed standardized data of all hospitalized patients
in all hospitals in Switzerland, so our results are valid for the whole country. The data set not
only included patient characteristics and treatment provided, but also, via linkage to hospital
characteristics data of the SFSO, it contained information on the personnel and technical infra-
structure of Swiss hospitals. By constructing the course of treatment of emergency STEMI
patients, we accounted for referrals and used the treatment information from all hospitals the
patient visited during treatment. To our knowledge, previous Swiss studies did not take into
account the treatments the patients received at all hospitals in case of hospital transfers [6–
9,14]. The studies reporting on patients monitored in the AMIS registry restricted their analysis
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to patients exclusively treated at hospitals collaborating in the AMIS registry [6,7,9]. As 39% of
all cases in our study were transferred at least once, it was important to consider all treatment
information available over the whole course of treatment.
Comparison with other studies
Like other studies of AMI patients, the receipt of optimal revascularization varied by age and
gender when we adjusted for age and other patient and hospital characteristics [6,15–18]. Stud-
ies in the US and UK observed higher rates of invasive cardiac procedures in hospitals with on-
site revascularization facilities [19,20]. In our univariable analysis, patients in hospitals with an
angiography device more often received revascularization, but in the multivariable analysis,
this association was no longer statistically significant.
Tung, et al, showed more PCI use among physicians who had high overall case volume [21].
Although the total number of annual hospitalizations does not directly reflect the frequency
with which a hospital performs PCI and CABG we found a trend for less revascularization
when admitted first to a small-volume hospital but the association was not significant. Just in
the stratified (by age and gender) sensitivity analysis (exclusion of cases admitted to hospitals
with less than 3000 cases/year, 85 years and more of age or patients which died the day of
admission) this trend was significant.
Insam and colleagues analyzed hospitalizations for AMI in Switzerland before 2009 to
determine if clinical management of AMI varied across seven major regions. They observed
significant geographical differences and explained that Swiss hospitals are largely autonomous
in defining their standards of care [8,14], but did not account for urbanization. Like studies
from Canada [22,23], we found no regional differences, either between the language regions or
between urban and rural hospitals.
Conclusions
Older patients and women were less likely to receive revascularization. Further research needs
to clarify whether this reflects differential application of treatment guidelines or limitations in
this kind of routine data.
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